Mesa Laboratories (MLAB) Receivables (2011 - 2025)

Mesa Laboratories has disclosed Receivables across 15 years of filings, most recently posting $40.2 million for Q4 2025.

• Receivables for Q4 2025 came in at $40.2 million, down 4.14% year-over-year; the trailing twelve-month figure through Dec 2025 was $40.2 million (down 4.14% YoY), and the FY2025 annual result was $42.0 million, up 7.46% from the prior year.
• Receivables came in at $40.2 million for Q4 2025 at Mesa Laboratories, roughly flat from $40.1 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $42.6 million in Q1 2023 to a low of $20.6 million in Q2 2021.
• The 5-year median for Receivables is $39.6 million (2025), against an average of $37.0 million.
• Across the five-year window, Receivables jumped 103.32% in 2022 and declined 15.03% in 2023, its largest moves.
• Mesa Laboratories' Receivables stood at $37.3 million in 2021, then climbed by 13.69% to $42.4 million in 2022, then declined by 15.03% to $36.0 million in 2023, then climbed by 16.51% to $42.0 million in 2024, then declined by 4.14% to $40.2 million in 2025.
• The last three Receivables figures came in at $40.2 million (Q4 2025), $40.1 million (Q3 2025), and $39.1 million (Q2 2025), per Business Quant data.